|
TMED7-TICAM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.499700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.360300E-02 |
| Normal-vs-Stage2 |
1.634830E-01 |
| Normal-vs-Stage3 |
3.426200E-02 |
| Normal-vs-Stage4 |
2.765700E-02 |
| Stage1-vs-Stage2 |
9.991800E-01 |
| Stage1-vs-Stage3 |
4.381400E-01 |
| Stage1-vs-Stage4 |
3.222800E-01 |
| Stage2-vs-Stage3 |
5.650200E-01 |
| Stage2-vs-Stage4 |
4.593600E-01 |
| Stage3-vs-Stage4 |
8.090400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.757500E-03 |
| Normal-vs-AfricanAmerican |
2.471400E-01 |
| Normal-vs-Asian |
2.899000E-01 |
| Caucasian-vs-AfricanAmerican |
1.59355999999056E-05 |
| Caucasian-vs-Asian |
4.321400E-01 |
| AfricanAmerican-vs-Asian |
1.926150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.201100E-03 |
| Normal-vs-Female |
2.047800E-01 |
| Male-vs-Female |
5.848300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.421000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.187700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.150170E-02 |
| Normal-vs-Age(81-100Yrs) |
4.489400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.072000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.256800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.746400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.152400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.952200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.414400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.232000E-01 |
| Normal-vs-Grade 2 |
3.309600E-02 |
| Normal-vs-Grade 3 |
6.395500E-02 |
| Normal-vs-Grade 4 |
1.730150E-02 |
| Grade 1-vs-Grade 2 |
6.238800E-01 |
| Grade 1-vs-Grade 3 |
6.471000E-01 |
| Grade 1-vs-Grade 4 |
2.356400E-01 |
| Grade 2-vs-Grade 3 |
8.988400E-01 |
| Grade 2-vs-Grade 4 |
2.615200E-01 |
| Grade 3-vs-Grade 4 |
2.345600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.839600E-02 |
| Normal-vs-ccB subtype |
4.642600E-03 |
| ccA subtype-vs-ccB subtype |
3.169000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.042050E-02 |
| Normal-vs-N1 |
4.209800E-01 |
| N0-vs-N1 |
8.440600E-01 |
|
|
